Skip to main content

Table 1 Patients’ general characteristics

From: Hemodialysis crossover study using a relative blood volume change-guided ultrafiltration control compared with standard hemodialysis: the BV-UFC study

  Characteristics at study initiation
Number of patients (men/women) 48 (15/33)
Age (years) 64.2 ± 7.3
HD duration (years) 7.5 ± 7.3
Dry weight (kg) 61.3 ± 15.7
Disease
 Diabetes mellitus 19
 Chronic glomerulonephritis 12
 Nephrosclerosis 3
 ADPKD 6
 Others 8
Comorbidities
 Cardiovascular disease 0/48
 Cerebrovascular disease 4/48
Medication, n (%)
 Antihypertensive medicines 40 (83.3)
 Renin-angiotensin system blocker 31 (64.6)
 Calcium channel blocker 33 (68.8)
 Beta blocker 12 (25.0)
 Alpha blocker 8 (16.7)
 Vitamin D analogue 39 (79.6)
 Phosphate binder 41 (85.4)
 Erythropoiesis-stimulating agent 46 (95.8)
Laboratory findings
 Hb (g/dL) 10.9 ± 0.8
 BUN (mg/dL) 67.4 ± 15.5
 Serum creatinine (mg/dL) 11.3 ± 2.3
 Na (mEq/L) 138.7 ± 1.7
 K (mEq/L) 5.0 ± 0.7
 Cl (mEq/L) 104.1 ± 2.7
 Ca (mg/dL) 8.7 ± 0.6
 P (mg/dL) 5.4 ± 1.3
 Total protein (g/dL) 6.4 ± 0.4
 Serum albumin (g/dL) 3.7 ± 0.3
  Standard HD HD with BV-UFC p-value
n (total number of HD sessions) 384 384  
Ultrafiltration (L/session) 2.80 ± 0.84 2.79 ± 0.80 0.780
Systolic blood pressure (mmHg) 151 ± 19 151 ± 19 0.933
Diastolic blood pressure (mmHg) 80 ± 11 80 ± 12 0.158
Heart rate (beats/min) 69.3 ± 9.3 69.8 ± 10.1 0.093
Kt/V urea 1.45 ± 0.25 1.48 ± 0.24 0.720
  1. HD hemodialysis, ADPKD autosomal dominant polycystic kidney disease, Hb hemoglobin, BUN blood urea nitrogen, BV-UFC blood volume change- guided ultrafiltration control